128 related articles for article (PubMed ID: 19414355)
1. Insulin-like growth factor-binding protein-3 in breast cancer: analysis with tissue microarray.
Sheen-Chen SM; Zhang H; Huang CC; Tang RP
Anticancer Res; 2009 Apr; 29(4):1131-5. PubMed ID: 19414355
[TBL] [Abstract][Full Text] [Related]
2. Signal transducer and activator of transcription 1 in breast cancer: analysis with tissue microarray.
Sheen-Chen SM; Huang CC; Tang RP; Yang CH; Chou FF; Eng HL
Anticancer Res; 2007; 27(4B):2481-6. PubMed ID: 17695542
[TBL] [Abstract][Full Text] [Related]
3. Lack of prognostic value of insulin-like growth factor-1 in patients with breast cancer: analysis with tissue microarray.
Sheen-Chen SM; Chou FF; Hsu W; Huang CC; Eng HL; Tang RP
Anticancer Res; 2007; 27(5B):3541-4. PubMed ID: 17972515
[TBL] [Abstract][Full Text] [Related]
4. Lack of prognostic value of topoisomerase II alpha in patients with breast cancer: analysis with tissue microarray.
Sheen-Chen SM; Huang CY; Zhang H; Huang CC; Tang RP
Anticancer Res; 2010 Jun; 30(6):2459-62. PubMed ID: 20651408
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of signal transducers and activators of transcription 3 in breast cancer.
Sheen-Chen SM; Huang CC; Tang RP; Chou FF; Eng HL
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2286-90. PubMed ID: 18768494
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of hepatocyte growth factor in patients with breast cancer.
Sheen-Chen SM; Liu YW; Eng HL; Chou FF
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):715-7. PubMed ID: 15767355
[TBL] [Abstract][Full Text] [Related]
7. Cortactin in breast cancer: analysis with tissue microarray.
Sheen-Chen SM; Huang CY; Liu YY; Huang CC; Tang RP
Anticancer Res; 2011 Jan; 31(1):293-7. PubMed ID: 21273613
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of the potential suppressor gene IGFBP-rP1 in human breast cancer is associated with inactivation of the retinoblastoma protein, cyclin E overexpression and increased proliferation in estrogen receptor negative tumors.
Landberg G; Ostlund H; Nielsen NH; Roos G; Emdin S; Burger AM; Seth A
Oncogene; 2001 Jun; 20(27):3497-505. PubMed ID: 11429696
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5 expression in breast cancer.
Mita K; Zhang Z; Ando Y; Toyama T; Hamaguchi M; Kobayashi S; Hayashi S; Fujii Y; Iwase H; Yamashita H
Jpn J Clin Oncol; 2007 Aug; 37(8):575-82. PubMed ID: 17675285
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a tumour suppressive function of IGF1-binding proteins in human breast cancer.
Subramanian A; Sharma AK; Banerjee D; Jiang WG; Mokbel K
Anticancer Res; 2007; 27(5B):3513-8. PubMed ID: 17972510
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of fatty acid-CoA ligase 4 in breast cancer.
Tsai CH; Sheen-Chen SM; Huang CY; Chen YJ; Chi SY; Ko SF; Lee YW; Liang JL; Hsu HW; Huang EY; Chen HC; Huang CC; Rau KM; Tang RP
Anticancer Res; 2014 Mar; 34(3):1239-43. PubMed ID: 24596366
[TBL] [Abstract][Full Text] [Related]
12. An evaluation of prognostic value of death-associated protein kinase 1 in breast cancer.
Chou SE; Huang CY; Sheen-Chen SM; Liu YW; Tsai CH; Lin YH; Huang CC; Tang RP
Anticancer Res; 2011 Oct; 31(10):3633-6. PubMed ID: 21965790
[TBL] [Abstract][Full Text] [Related]
13. Expression of epidermal growth factor receptor in relation to BRCA1 status, basal-like markers and prognosis in breast cancer.
Arnes JB; Bégin LR; Stefansson I; Brunet JS; Nielsen TO; Foulkes WD; Akslen LA
J Clin Pathol; 2009 Feb; 62(2):139-46. PubMed ID: 18682421
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of focal adhesion kinase in breast cancer by tissue microarrays.
Sheen-Chen SM; Huang CY; Chan YC; Tsai CH; Chi SY; Wu SC; Huang CC; Tang RP; Eng HL; Ko SF; Lee YW; Liang JL; Huang EY; Chen HC; Rau KM
Anticancer Res; 2013 Mar; 33(3):1169-73. PubMed ID: 23482798
[TBL] [Abstract][Full Text] [Related]
15. Peptide concentrations and mRNA expression of IGF-I, IGF-II and IGFBP-3 in breast cancer and their associations with disease characteristics.
Mu L; Katsaros D; Wiley A; Lu L; de la Longrais IA; Smith S; Khubchandani S; Sochirca O; Arisio R; Yu H
Breast Cancer Res Treat; 2009 May; 115(1):151-62. PubMed ID: 18481170
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor binding protein-2 is a novel therapeutic target associated with breast cancer.
So AI; Levitt RJ; Eigl B; Fazli L; Muramaki M; Leung S; Cheang MC; Nielsen TO; Gleave M; Pollak M
Clin Cancer Res; 2008 Nov; 14(21):6944-54. PubMed ID: 18980989
[TBL] [Abstract][Full Text] [Related]
17. The expression and function of IGFBP-3 in normal and malignant breast tissue.
McCarthy K; Laban C; McVittie CJ; Ogunkolade W; Khalaf S; Bustin S; Carpenter R; Jenkins PJ
Anticancer Res; 2009 Oct; 29(10):3785-90. PubMed ID: 19846909
[TBL] [Abstract][Full Text] [Related]
18. Expression and prognostic significance of metalloproteases and their inhibitors in luminal A and basal-like phenotypes of breast carcinoma.
González LO; Corte MD; Junquera S; González-Fernández R; del Casar JM; García C; Andicoechea A; Vázquez J; Pérez-Fernández R; Vizoso FJ
Hum Pathol; 2009 Sep; 40(9):1224-33. PubMed ID: 19439346
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase-1 and -3 protein expression in human breast cancer: a tissue microarray analysis.
Krusche CA; Wülfing P; Kersting C; Vloet A; Böcker W; Kiesel L; Beier HM; Alfer J
Breast Cancer Res Treat; 2005 Mar; 90(1):15-23. PubMed ID: 15770522
[TBL] [Abstract][Full Text] [Related]
20. Parafibromin expression in breast cancer: a novel marker for prognostication?
Selvarajan S; Sii LH; Lee A; Yip G; Bay BH; Tan MH; Teh BT; Tan PH
J Clin Pathol; 2008 Jan; 61(1):64-7. PubMed ID: 17468290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
